Viral Hepatitis A, B and C in a Group of Transgender Women in Central Brazil

Detalhes bibliográficos
Autor(a) principal: Ferri, Lucila Pessuti
Data de Publicação: 2022
Outros Autores: Junqueira, Priscilla dos Santos, Almeida, Mayara Maria Souza de, Oliveira, Mariana Gomes, Oliveira, Brunna Rodrigues de, Silva, Bruno Vinícius Diniz e, Magalhães, Larissa Silva, Villar, Lívia Melo, Caetano, Karlla Antonieta Amorim, Souza, Márcia Maria, Carneiro, Megmar Aparecida dos Santos, Martins, Regina Maria Bringel, Teles, Sheila Araujo
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/56416
Resumo: Universidade Federal de Goiás. Faculdade de Enfermagem. Gioânia, GO, Brasil.
id CRUZ_3020b5a904915540cd986e300d8f8c1d
oai_identifier_str oai:www.arca.fiocruz.br:icict/56416
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Ferri, Lucila PessutiJunqueira, Priscilla dos SantosAlmeida, Mayara Maria Souza deOliveira, Mariana GomesOliveira, Brunna Rodrigues deSilva, Bruno Vinícius Diniz eMagalhães, Larissa SilvaVillar, Lívia MeloCaetano, Karlla Antonieta AmorimSouza, Márcia MariaCarneiro, Megmar Aparecida dos SantosMartins, Regina Maria BringelTeles, Sheila Araujo2023-01-10T11:24:16Z2023-01-10T11:24:16Z2022FERRI, Lucila Pessuti et al. Viral Hepatitis A, B and C in a Group of Transgender Women in Central Brazil. Tropical Medicine and Infectious Disease, v. 7, 269, p. 1 - 11, Sept. 2022.2414-6366https://www.arca.fiocruz.br/handle/icict/5641610.3390/ tropicalmed7100269engMDPIHepatite AHepatite BHepatite CImunogenicidadeMulheres transexuaisVacinaçãoHepatite viralHepatitis AHepatitis BHepatitis CImmunogenicityTransgender womenVaccinationViral hepatitisViral Hepatitis A, B and C in a Group of Transgender Women in Central Brazilinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleUniversidade Federal de Goiás. Faculdade de Enfermagem. Gioânia, GO, Brasil.Universidade Federal de Goiás. Faculdade de Enfermagem. Gioânia, GO, Brasil.Universidade Federal de Goiás. Faculdade de Enfermagem. Gioânia, GO, Brasil.Universidade Federal de Goiás. Faculdade de Enfermagem. Gioânia, GO, Brasil.Universidade Federal de Goiás. Instituto de Patologia Tropical e Saúde Pública. Goiânia, GO, Brasil.Universidade Federal de Goiás. Instituto de Patologia Tropical e Saúde Pública. Goiânia, GO, Brasil.Universidade Federal de Goiás. Faculdade de Enfermagem. Gioânia, GO, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hepatities Virais. Rio de Janeiro, RJ, Brasil.Universidade Federal de Goiás. Faculdade de Enfermagem. Gioânia, GO, Brasil.Universidade Federal de Goiás. Faculdade de Enfermagem. Gioânia, GO, Brasil.Universidade Federal de Goiás. Instituto de Patologia Tropical e Saúde Pública. Goiânia, GO, Brasil.Universidade Federal de Goiás. Instituto de Patologia Tropical e Saúde Pública. Goiânia, GO, Brasil.Universidade Federal de Goiás. Faculdade de Enfermagem. Gioânia, GO, Brasil.Transgender women (TGW) have limited access to affordable viral hepatitis testing, hepatitis B vaccination, and treatment. We aimed to estimate the prevalence of viral hepatitis A, B, and C, as well as to compare the adherence and immunogenicity of two hepatitis B vaccine schedules among TGW in Central Brazil. A total of 440 TGW were interviewed and tested for hepatitis A, B, and C serological markers from 2017 to 2018. The hepatitis B vaccine was offered to 230 eligible TGW: 112 received a super accelerated hepatitis B vaccine schedule (G1) and 118 a standard schedule (G2). The antibody against the hepatitis A virus (HAV) was detected in 75.63% of the participants, and 12.3% of the TGW were exposed to the hepatitis B virus (HBV). Two (0.46%) participants were HBV carriers. Only 41.5% of the participants showed a serological profile of hepatitis B vaccination. The antibody against the hepatitis C virus (anti-HCV) was found in six participants (1.37%). Of the TGW who received the first vaccine dose, 62 (55.36%) and 49 (41.52%) in G1 and G2, respectively, received three doses (p = 0.036). The vaccine response was evaluated in 28 G1 and 22 G2 TGW; of these, 89.3% and 100% developed protective anti-hepatitis B surface-antigen titers, respectively (p = 0.113). Since one-third of younger transgender women are susceptible to HAV, hepatitis B immunization is low, and the anti-HCV rate is higher in this group than in the general population in Central Brazil, public-health attention is warranted. The super-accelerated scheme demonstrated better adhesion and good immunogenicity, suggesting that it would be a more cost-effective solution.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/56416/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALLucilaFerri_liviaVilar_etal-IOC_2022.pdfLucilaFerri_liviaVilar_etal-IOC_2022.pdfapplication/pdf633401https://www.arca.fiocruz.br/bitstream/icict/56416/2/LucilaFerri_liviaVilar_etal-IOC_2022.pdf536bb2026a5b99abe307f375da53dd67MD52icict/564162023-09-04 11:10:43.246oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-09-04T14:10:43Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.en_US.fl_str_mv Viral Hepatitis A, B and C in a Group of Transgender Women in Central Brazil
title Viral Hepatitis A, B and C in a Group of Transgender Women in Central Brazil
spellingShingle Viral Hepatitis A, B and C in a Group of Transgender Women in Central Brazil
Ferri, Lucila Pessuti
Hepatite A
Hepatite B
Hepatite C
Imunogenicidade
Mulheres transexuais
Vacinação
Hepatite viral
Hepatitis A
Hepatitis B
Hepatitis C
Immunogenicity
Transgender women
Vaccination
Viral hepatitis
title_short Viral Hepatitis A, B and C in a Group of Transgender Women in Central Brazil
title_full Viral Hepatitis A, B and C in a Group of Transgender Women in Central Brazil
title_fullStr Viral Hepatitis A, B and C in a Group of Transgender Women in Central Brazil
title_full_unstemmed Viral Hepatitis A, B and C in a Group of Transgender Women in Central Brazil
title_sort Viral Hepatitis A, B and C in a Group of Transgender Women in Central Brazil
author Ferri, Lucila Pessuti
author_facet Ferri, Lucila Pessuti
Junqueira, Priscilla dos Santos
Almeida, Mayara Maria Souza de
Oliveira, Mariana Gomes
Oliveira, Brunna Rodrigues de
Silva, Bruno Vinícius Diniz e
Magalhães, Larissa Silva
Villar, Lívia Melo
Caetano, Karlla Antonieta Amorim
Souza, Márcia Maria
Carneiro, Megmar Aparecida dos Santos
Martins, Regina Maria Bringel
Teles, Sheila Araujo
author_role author
author2 Junqueira, Priscilla dos Santos
Almeida, Mayara Maria Souza de
Oliveira, Mariana Gomes
Oliveira, Brunna Rodrigues de
Silva, Bruno Vinícius Diniz e
Magalhães, Larissa Silva
Villar, Lívia Melo
Caetano, Karlla Antonieta Amorim
Souza, Márcia Maria
Carneiro, Megmar Aparecida dos Santos
Martins, Regina Maria Bringel
Teles, Sheila Araujo
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Ferri, Lucila Pessuti
Junqueira, Priscilla dos Santos
Almeida, Mayara Maria Souza de
Oliveira, Mariana Gomes
Oliveira, Brunna Rodrigues de
Silva, Bruno Vinícius Diniz e
Magalhães, Larissa Silva
Villar, Lívia Melo
Caetano, Karlla Antonieta Amorim
Souza, Márcia Maria
Carneiro, Megmar Aparecida dos Santos
Martins, Regina Maria Bringel
Teles, Sheila Araujo
dc.subject.other.en_US.fl_str_mv Hepatite A
Hepatite B
Hepatite C
Imunogenicidade
Mulheres transexuais
Vacinação
Hepatite viral
topic Hepatite A
Hepatite B
Hepatite C
Imunogenicidade
Mulheres transexuais
Vacinação
Hepatite viral
Hepatitis A
Hepatitis B
Hepatitis C
Immunogenicity
Transgender women
Vaccination
Viral hepatitis
dc.subject.en.en_US.fl_str_mv Hepatitis A
Hepatitis B
Hepatitis C
Immunogenicity
Transgender women
Vaccination
Viral hepatitis
description Universidade Federal de Goiás. Faculdade de Enfermagem. Gioânia, GO, Brasil.
publishDate 2022
dc.date.issued.fl_str_mv 2022
dc.date.accessioned.fl_str_mv 2023-01-10T11:24:16Z
dc.date.available.fl_str_mv 2023-01-10T11:24:16Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv FERRI, Lucila Pessuti et al. Viral Hepatitis A, B and C in a Group of Transgender Women in Central Brazil. Tropical Medicine and Infectious Disease, v. 7, 269, p. 1 - 11, Sept. 2022.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/56416
dc.identifier.issn.en_US.fl_str_mv 2414-6366
dc.identifier.doi.none.fl_str_mv 10.3390/ tropicalmed7100269
identifier_str_mv FERRI, Lucila Pessuti et al. Viral Hepatitis A, B and C in a Group of Transgender Women in Central Brazil. Tropical Medicine and Infectious Disease, v. 7, 269, p. 1 - 11, Sept. 2022.
2414-6366
10.3390/ tropicalmed7100269
url https://www.arca.fiocruz.br/handle/icict/56416
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/56416/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/56416/2/LucilaFerri_liviaVilar_etal-IOC_2022.pdf
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
536bb2026a5b99abe307f375da53dd67
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009153898053632

Registros relacionados